181 related articles for article (PubMed ID: 16140739)
1. Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.
Marchlik E; Kalman R; Rosenberg N
J Virol; 2005 Sep; 79(18):11618-26. PubMed ID: 16140739
[TBL] [Abstract][Full Text] [Related]
2. Activation of an oncogenic microRNA cistron by provirus integration.
Wang CL; Wang BB; Bartha G; Li L; Channa N; Klinger M; Killeen N; Wabl M
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18680-4. PubMed ID: 17121985
[TBL] [Abstract][Full Text] [Related]
3. Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.
Zhao W; Akkawi C; Mougel M; Ross SR
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641479
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic studies on abelson-virus-induced mouse leukemias.
Klein G; Ohno S; Rosenberg N; Wiener F; Spira J; Baltimore D
Int J Cancer; 1980 Jun; 25(6):805-11. PubMed ID: 14768711
[TBL] [Abstract][Full Text] [Related]
5. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
6. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
7. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site.
Hasegawa M; Yamaguchi S; Aizawa S; Ikeda H; Tatsumi K; Noda Y; Hirokawa K; Kitagawa M
Leuk Res; 2005 Aug; 29(8):933-42. PubMed ID: 15978944
[TBL] [Abstract][Full Text] [Related]
8. Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?
Baxter EW; Blyth K; Donehower LA; Cameron ER; Onions DE; Neil JC
J Virol; 1996 Apr; 70(4):2095-100. PubMed ID: 8642629
[TBL] [Abstract][Full Text] [Related]
9. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
Nielsen AA; Sørensen AB; Schmidt J; Pedersen FS
J Virol; 2005 Jan; 79(1):67-78. PubMed ID: 15596802
[TBL] [Abstract][Full Text] [Related]
10. Rmcf2, a xenotropic provirus in the Asian mouse species Mus castaneus, blocks infection by polytropic mouse gammaretroviruses.
Wu T; Yan Y; Kozak CA
J Virol; 2005 Aug; 79(15):9677-84. PubMed ID: 16014929
[TBL] [Abstract][Full Text] [Related]
11. Carboxyl-terminal determinants of Abelson protein important for lymphoma induction.
Parmar K; Huebner RC; Rosenberg N
J Virol; 1991 Dec; 65(12):6478-85. PubMed ID: 1942244
[TBL] [Abstract][Full Text] [Related]
12. Genetic profile of insertion mutations in mouse leukemias and lymphomas.
Hansen GM; Skapura D; Justice MJ
Genome Res; 2000 Feb; 10(2):237-43. PubMed ID: 10673281
[TBL] [Abstract][Full Text] [Related]
13. Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.
Barrett BS; Guo K; Harper MS; Li SX; Heilman KJ; Davidson NO; Santiago ML
Virology; 2014 Nov; 468-470():601-608. PubMed ID: 25303118
[TBL] [Abstract][Full Text] [Related]
14. SERINC5 Potently Restricts Retrovirus Infection
Timilsina U; Umthong S; Lynch B; Stablewski A; Stavrou S
mBio; 2020 Jul; 11(4):. PubMed ID: 32665269
[TBL] [Abstract][Full Text] [Related]
15. Serial infection of diverse host (Mus) genotypes rapidly impedes pathogen fitness and virulence.
Kubinak JL; Cornwall DH; Hasenkrug KJ; Adler FR; Potts WK
Proc Biol Sci; 2015 Jan; 282(1798):20141568. PubMed ID: 25392466
[TBL] [Abstract][Full Text] [Related]
16. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
[TBL] [Abstract][Full Text] [Related]
17. Absence of p53 complements defects in Abelson murine leukemia virus signaling.
Unnikrishnan I; Rosenberg N
J Virol; 2003 Jun; 77(11):6208-15. PubMed ID: 12743277
[TBL] [Abstract][Full Text] [Related]
18. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
[TBL] [Abstract][Full Text] [Related]
19. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
[TBL] [Abstract][Full Text] [Related]
20. Chronic myeloproliferative disease induced by site-specific integration of Abelson murine leukemia virus-infected hemopoietic stem cells.
Han XD; Wong PM; Chung SW
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10129-33. PubMed ID: 1682923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
